4//SEC Filing
RITTER PHARMACEUTICALS INC 4
Accession 0001382963-16-000251
$AIXCCIK 0001460702operating
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 9:53 PM ET
Size
5.3 KB
Accession
0001382963-16-000251
Insider Transaction Report
Form 4
Ritter Andrew J
DirectorPresident
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2016-10-25+140,044→ 140,044 totalExercise: $2.60Exp: 2026-10-25→ Common Stock (140,044 underlying)
Footnotes (1)
- [F1]The option vests ratably over 48 months following the public disclosure of top-line data results from the Issuer's Phase 2b/3 clinical trial.
Documents
Issuer
RITTER PHARMACEUTICALS INC
CIK 0001460702
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001460702
Filing Metadata
- Form type
- 4
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 9:53 PM ET
- Size
- 5.3 KB